Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1963 1
1966 1
1976 1
1977 1
1980 1
1982 3
1984 1
1986 1
1988 1
1990 1
1991 2
1994 1
1995 1
1996 5
1997 9
1998 2
1999 4
2000 7
2002 3
2003 9
2004 2
2005 4
2006 1
2007 5
2008 6
2009 7
2010 6
2011 4
2012 9
2013 10
2014 7
2015 2
2016 3
2017 3
2018 3
2019 4
2020 2
2021 3
2023 4
2024 5
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

145 results

Results by year

Filters applied: . Clear all
Page 1
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup.
Sperling RA, Jack CR Jr, Black SE, Frosch MP, Greenberg SM, Hyman BT, Scheltens P, Carrillo MC, Thies W, Bednar MM, Black RS, Brashear HR, Grundman M, Siemers ER, Feldman HH, Schindler RJ. Sperling RA, et al. Among authors: grundman m. Alzheimers Dement. 2011 Jul;7(4):367-85. doi: 10.1016/j.jalz.2011.05.2351. Alzheimers Dement. 2011. PMID: 21784348 Free PMC article. Review.
Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease.
Salloway S, Wojtowicz J, Voyle N, Lane CA, Klein G, Lyons M, Rossomanno S, Mazzo F, Bullain S, Barkhof F, Bittner T, Schneider A, Grundman M, Aldea R, Boada M, Smith J, Doody R. Salloway S, et al. Among authors: grundman m. JAMA Neurol. 2025 Jan 1;82(1):19-29. doi: 10.1001/jamaneurol.2024.3937. JAMA Neurol. 2025. PMID: 39556389 Free PMC article. Clinical Trial.
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. Among authors: grundman m. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
Value-Generating Exploratory Trials in Neurodegenerative Dementias.
Friedman LG, McKeehan N, Hara Y, Cummings JL, Matthews DC, Zhu J, Mohs RC, Wang D, Hendrix SB, Quintana M, Schneider LS, Grundman M, Dickson SP, Feldman HH, Jaeger J, Finger EC, Ryan JM, Niehoff D, Dickinson SL, Markowitz JT, Owen M, Travaglia A, Fillit HM. Friedman LG, et al. Among authors: grundman m. Neurology. 2021 May 18;96(20):944-954. doi: 10.1212/WNL.0000000000011774. Epub 2021 Mar 5. Neurology. 2021. PMID: 33674360 Free PMC article. Review.
Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial.
Dam T, Boxer AL, Golbe LI, Höglinger GU, Morris HR, Litvan I, Lang AE, Corvol JC, Aiba I, Grundman M, Yang L, Tidemann-Miller B, Kupferman J, Harper K, Kamisoglu K, Wald MJ, Graham DL, Gedney L, O'Gorman J, Haeberlein SB; PASSPORT Study Group. Dam T, et al. Among authors: grundman m. Nat Med. 2021 Aug;27(8):1451-1457. doi: 10.1038/s41591-021-01455-x. Epub 2021 Aug 12. Nat Med. 2021. PMID: 34385707 Clinical Trial.
Low-dose interleukin-2 in patients with mild to moderate Alzheimer's disease: a randomized clinical trial.
Faridar A, Gamez N, Li D, Wang Y, Boradia R, Thome AD, Zhao W, Beers DR, Thonhoff JR, Nakawah MO, Román GC, Volpi JJ, Toledo JB, George M, Davis CS, Pascual B, Grundman M, Masdeu JC, Appel SH. Faridar A, et al. Among authors: grundman m. Alzheimers Res Ther. 2025 Jul 4;17(1):146. doi: 10.1186/s13195-025-01791-x. Alzheimers Res Ther. 2025. PMID: 40615880 Free PMC article. Clinical Trial.
Drug Development.
Lizama BN, Pandey K, Cho E, Caldwell J, Caro VD, Duong DM, Shin R, Levey AI, Seyfried NT, Grundman M, Teunissen CE, Caggiano AO, Hamby ME. Lizama BN, et al. Among authors: grundman m. Alzheimers Dement. 2025 Dec;21 Suppl 5:e102120. doi: 10.1002/alz70859_102120. Alzheimers Dement. 2025. PMID: 41449100 Clinical Trial.
Drug Development.
Galvin JE, Hamby ME, Iaci J, Grundman M, Caggiano AO. Galvin JE, et al. Among authors: grundman m. Alzheimers Dement. 2025 Dec;21 Suppl 5:e106890. doi: 10.1002/alz70859_106890. Alzheimers Dement. 2025. PMID: 41449074 Clinical Trial.
Drug Development.
Faridar A, Gamez N, Grundman M, Pascual B, Masdeu JC, Appel SH. Faridar A, et al. Among authors: grundman m. Alzheimers Dement. 2025 Dec;21 Suppl 5(Suppl 5):e101215. doi: 10.1002/alz70859_101215. Alzheimers Dement. 2025. PMID: 41447560 Free PMC article. Clinical Trial.
Drug Development.
Grundman M, Catalano S, Hamby ME, Devins T, Iaci J, Caggiano AO. Grundman M, et al. Alzheimers Dement. 2025 Dec;21 Suppl 5:e106858. doi: 10.1002/alz70859_106858. Alzheimers Dement. 2025. PMID: 41451867 Clinical Trial.
145 results